✦ LIBER ✦

Randomized phase II study of docetaxel plus cisplatin versus docetaxel plus irinotecan in advanced non-small-cell lung cancer. A West Japan Thoracic Oncology Group Study

✍ Scribed by Saito, H; Yamamoto, N; Negoro, S; Nakagawa, K; Matsui, K; Kawahara, M; Takada, Y; Fukuoka, M; Ariyoshi, Y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised phase II study of docetaxel/c

✍ Yamamoto, N; Fukuoka, M; Negoro, S-I; Nakagawa, K; Saito, H; Matsui, K; Kawahara 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB

Docetaxel plus cisplatin versus docetaxe

✍ V. Georgoulias; E. Papadakis; A. Alexopoulos; E. Stavrinidis; E. Bania; A. Rapti 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Phase II and Phase III Trials: Docetaxel

📂 Article 📅 2001 🏛 CIG Media Group, LP. 🌐 English ⚖ 70 KB

Docetaxel Versus Docetaxel/Cisplatin in

✍ V. Georgoulias; A.G. Pallis; C. Kourousis; A. Alexopoulos; A. Ardavanis; A. Agel 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 150 KB

Doublet regimen of cisplatin plus doceta

✍ Takashi Seto; Yoriko Takezako; Hiroko Nakamura; Kayo Takeda; Fumiko Inoue; Hiros 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 193 KB

Randomized, multicenter, phase II study

✍ Mazzanti, Paola; Massacesi, Cristian; Rocchi, Marco B.L.; Mattioli, Rodolfo; Lip 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 216 KB